Compare ALKS & SPXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | SPXC |
|---|---|---|
| Founded | 1987 | 1912 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 9.7B |
| IPO Year | 2012 | 1994 |
| Metric | ALKS | SPXC |
|---|---|---|
| Price | $43.20 | $166.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 14 |
| Target Price | $56.21 | ★ $252.79 |
| AVG Volume (30 Days) | ★ 2.1M | 590.3K |
| Earning Date | 10-30-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.08 |
| EPS | N/A | ★ 2.73 |
| Revenue | $1,475,899,000.00 | ★ $2,265,100,000.00 |
| Revenue This Year | $23.54 | $22.20 |
| Revenue Next Year | $6.53 | $14.68 |
| P/E Ratio | ★ N/A | $60.67 |
| Revenue Growth | N/A | ★ 14.17 |
| 52 Week Low | $27.00 | $161.61 |
| 52 Week High | $55.67 | $251.08 |
| Indicator | ALKS | SPXC |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 37.05 |
| Support Level | $39.84 | $166.17 |
| Resistance Level | $43.22 | $180.49 |
| Average True Range (ATR) | 1.21 | 4.84 |
| MACD | 0.32 | 0.61 |
| Stochastic Oscillator | 81.72 | 30.71 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.